This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hengrui (USA) Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations by Andy J Ommen: Pioneering Cancer Treatment Compounds
Introduction
Andy J Ommen, an accomplished inventor located in Laramie, Wyoming, has made significant strides in the field of pharmaceutical compounds. With her innovative approach, she has contributed to the development of new derivatives that hold promise for cancer treatment.
Latest Patents
Ommen is credited with a patent for her work on 2-arylimidazo[1,2-B]pyridazine, 2-phenylimidazo[1,2-A]pyridine, and 2-phenylimidazo[1,2-A]pyrazine derivatives. The patent discloses various compounds characterized by a specific formula (I), where components such as X, Y, A, R, and others are defined in detail. Additionally, the patent outlines pharmaceutically acceptable salts of these compounds, along with formulations that can be used in therapeutic applications.
Career Highlights
Andy J Ommen is currently employed at Hengrui (USA) Ltd., where she continues to engage in research and development of innovative pharmaceutical solutions. Her singular patent exemplifies her commitment to finding new avenues for treating serious health conditions such as cancer.
Collaborations
Ommen collaborates with notable coworkers, including Robert N Atkinson and James Marvin Veal. Together, they contribute to a dynamic research environment that fosters innovation and advancement in drug development.
Conclusion
Through her patent and collaborative efforts, Andy J Ommen demonstrates the profound impact that dedicated inventors can have on medical science. Her work is a testament to the potential of innovative compounds in transforming treatment options for cancer and beyond.